Cannabis biotech firm Front Range Biosciences locks in $10 mln Series A


Lafayette, Colorado-based Front Range Biosciences, a cannabis biotech company, has raised $10 million in Series A financing. The investors included Phyto Partners, WelCan Capital, Salveo Capital, Cornerstone Opportunity Partners, Sand Hill Angels, Harvard Business School Alumni Angels of New York, New York Angels and Altitude Investment Management.

Source: Press Release

Do you want exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more? Get your FREE trial to Buyouts! Or subscribe now!